Skip to main content

Aneurysm, Intracranial

1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Cerus
CerusCA - Concord
1 program
1
Contour Neurovascular SystemPhase 41 trial
Active Trials
NCT04852783Active Not Recruiting250Est. Feb 2030
Stryker
StrykerCA - San Jose
2 programs
Surpass Evolve Flow Diverter SystemN/A1 trial
Surpass Streamline Flow Diverter SystemN/A1 trial
Active Trials
NCT04195568Active Not Recruiting248Est. Sep 2028
NCT05544045Terminated11Est. Sep 2023
Evasc Medical Systems
Evasc Medical SystemsBC - Vancouver
1 program
Electrolytic eCLIPs Bifurcation SystemN/A1 trial
Active Trials
NCT04886505Withdrawn0Est. Sep 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
CerusContour Neurovascular System
StrykerSurpass Streamline Flow Diverter System
Evasc Medical SystemsElectrolytic eCLIPs Bifurcation System
StrykerSurpass Evolve Flow Diverter System

Clinical Trials (4)

Total enrollment: 509 patients across 4 trials

NCT04852783CerusContour Neurovascular System

US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair

Start: Aug 2021Est. completion: Feb 2030250 patients
Phase 4Active Not Recruiting
NCT05544045StrykerSurpass Streamline Flow Diverter System

China Surpass Streamline Post-Market Study

Start: Jun 2022Est. completion: Sep 202311 patients
N/ATerminated
NCT04886505Evasc Medical SystemsElectrolytic eCLIPs Bifurcation System

An EFS Assessing the Electrolytic eCLIPs System for Treatment of Intracranial Aneurysms

Start: Jan 2022Est. completion: Sep 20230
N/AWithdrawn
NCT04195568StrykerSurpass Evolve Flow Diverter System

Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System

Start: Jul 2020Est. completion: Sep 2028248 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.